LANCE E. THIBAULT - 16 May 2023 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role: Chief Financial Officer
Signature: /s/ Matthew P. Blischak, Attorney-in-Fact
Issuer symbol: FNCH
Transactions as of: 16 May 2023
Net transactions value: $0
Form type: 3
Filing time: 16 May 2023, 16:05:22 UTC
Previous filing: 03 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney